-
IASO Biotherapeutics Raises $60 Million in Series B
Post on 3/24/20
-
Most Aggressive States Against the Coronavirus – WalletHub Study
Post on 3/24/20
-
Why Berkshire Hathaway, Lockheed Martin, and Harley-Davidson Stocks All Dropped This Morning
Post on 3/24/20
-
Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
Post on 3/24/20
-
Why Raytheon, General Dynamics, and United Technologies Stocks All Fell 10% Today
Post on 3/24/20
-
New York to Start Clinical Trials of Anti-Malaria Drugs for COVID-19
Post on 3/24/20
-
Eyenovia Announces Approximately $6.0 Million Private Placement
Post on 3/23/20
-
Hoth Therapeutics Announces Proposed Public Offering of Common Stock
Post on 3/23/20
-
DLA Piper launches Coronavirus Resource Center
Post on 3/23/20
-
Fortress Biotech Announces Up to $5M Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
Post on 3/23/20
-
Hoth Therapeutics Announces Agreement to Joint Development of a Self-Assembling Vaccine
Post on 3/23/20
-
Pfizer Is A Buy Now
Post on 3/23/20
-
Johnson and Johnson: A Safe Haven in Recession
Post on 3/23/20
-
Why Is Everyone Talking About Regeneron?
Post on 3/23/20
-
National Kidney Foundation Honors Janssen Pharmaceutical Companies of Johnson & Johnson with 2020 Corporate Innovator Award
Post on 3/20/20
-
Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer
Post on 3/20/20
-
Chembio Diagnostics Receives $4M Purchase Order from Bio-Manguinhos
Post on 3/20/20
-
Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment
Post on 3/20/20
-
GE Healthcare Boosts Its COVID-19 Efforts
Post on 3/20/20
-
Bristol Myers Squibb Hints at Further Acquisition Plans With New Executive Hire
Post on 3/20/20
-
2020 Women on Boards Honors Tabula Rasa HealthCare for Having at Least 20% Women on its Corporate Board
Post on 3/19/20
-
Trump Signs Coronavirus Relief Bill Into Law
Post on 3/19/20
-
Cigna Reports Pricing Of $1.45B Of Notes Under Tender Offers
Post on 3/19/20
-
J&J Files U.S. Application For MS Med Ponesimod
Post on 3/19/20
-
Pfizer's Abrocitinib Successful In Dermatitis Study
Post on 3/19/20
New York
